GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (BOM:524774) » Definitions » E10

NGL Fine-Chem (BOM:524774) E10 : ₹47.39 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is NGL Fine-Chem E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

NGL Fine-Chem's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹19.910. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹47.39 for the trailing ten years ended in Mar. 2024.

During the past 12 months, NGL Fine-Chem's average E10 Growth Rate was 17.60% per year. During the past 3 years, the average E10 Growth Rate was 19.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of NGL Fine-Chem was 19.30% per year. The lowest was 19.30% per year. And the median was 19.30% per year.

As of today (2024-06-09), NGL Fine-Chem's current stock price is ₹2297.80. NGL Fine-Chem's E10 for the quarter that ended in Mar. 2024 was ₹47.39. NGL Fine-Chem's Shiller PE Ratio of today is 48.49.

During the past 13 years, the highest Shiller PE Ratio of NGL Fine-Chem was 113.98. The lowest was 29.71. And the median was 47.65.


NGL Fine-Chem E10 Historical Data

The historical data trend for NGL Fine-Chem's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGL Fine-Chem E10 Chart

NGL Fine-Chem Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 27.93 35.77 40.29 47.39

NGL Fine-Chem Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.29 42.13 43.74 45.60 47.39

Competitive Comparison of NGL Fine-Chem's E10

For the Drug Manufacturers - General subindustry, NGL Fine-Chem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NGL Fine-Chem's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where NGL Fine-Chem's Shiller PE Ratio falls into.



NGL Fine-Chem E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NGL Fine-Chem's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=19.91/153.0345*153.0345
=19.910

Current CPI (Mar. 2024) = 153.0345.

NGL Fine-Chem Quarterly Data

per share eps CPI Adj_EPS
201406 2.840 94.103 4.619
201409 3.700 96.780 5.851
201412 2.320 96.780 3.669
201503 4.730 97.163 7.450
201506 4.490 99.841 6.882
201509 4.140 101.753 6.226
201512 4.490 102.901 6.678
201603 5.460 102.518 8.150
201606 6.680 105.961 9.648
201609 4.740 105.961 6.846
201612 6.812 105.196 9.910
201703 5.590 105.196 8.132
201706 2.590 107.109 3.701
201709 5.540 109.021 7.777
201712 6.870 109.404 9.610
201803 4.970 109.786 6.928
201806 8.040 111.317 11.053
201809 7.150 115.142 9.503
201812 6.590 115.142 8.759
201903 11.030 118.202 14.280
201906 8.410 120.880 10.647
201909 3.800 123.175 4.721
201912 1.820 126.235 2.206
202003 -0.270 124.705 -0.331
202006 15.190 127.000 18.304
202009 25.590 130.118 30.097
202012 28.670 130.889 33.521
202103 22.400 131.771 26.015
202106 30.960 134.084 35.336
202109 22.520 135.847 25.369
202112 16.100 138.161 17.833
202203 10.950 138.822 12.071
202206 0.840 142.347 0.903
202209 7.560 144.661 7.998
202212 10.500 145.763 11.024
202303 14.550 146.865 15.161
202306 13.770 150.280 14.022
202309 16.960 151.492 17.133
202312 16.240 152.924 16.252
202403 19.910 153.035 19.910

Add all the adjusted EPS together and divide 10 will get our e10.


NGL Fine-Chem  (BOM:524774) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

NGL Fine-Chem's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2297.80/47.39
=48.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of NGL Fine-Chem was 113.98. The lowest was 29.71. And the median was 47.65.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


NGL Fine-Chem E10 Related Terms

Thank you for viewing the detailed overview of NGL Fine-Chem's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


NGL Fine-Chem (BOM:524774) Business Description

Traded in Other Exchanges
Address
301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.

NGL Fine-Chem (BOM:524774) Headlines

No Headlines